Opioid-dopamine interaction in
planaria: a behavioral study
by
Passarelli F, Merante A, Pontieri FE,
Margotta V, Venturini G, Palladini G
Department of Neuroscience,
University La Sapienza, Rome, Italy.
Comp Biochem Physiol
C Pharmacol Toxicol Endocrinol 1999 Sep;124(1):51-5

ABSTRACT

The behavioral response of planaria to the exposure to selective opioid agonists was studied. The mu agonist [d-ala2, N-methyl-Phe4,Gly5-ol]enkephalin (DAMGO) and the 6 agonist [D-Pen2, D-Pen5]enkephalin (DPDPE) failed to alter motor activity at all doses tested. Low doses of the selective kappa agonist (+/-)-trans-U-50-trans-3,4-dichloro-N-methyl-N[2-(1-pyrrodinyl)-cyclohexyl]benzene acetamide methasulphonate (U50, 488) and bremazocine-HCl increased motor activity leading to C-like position (CLP) and screw-like hyperkinesia (SLH). These changes were identical to those seen previously with the exposure to D2 or D1 dopamine receptor agonists, respectively. Higher doses of kappa agonists produced the enhancement of CLP and SLH together with robust snake-like movements (SLM). This latter response, that was typical of stimulation of kappa opioid receptors, was blocked by co-exposure to naloxone or the selective kappa antagonist Nor-binaltorphimine (Nor-BNI). Finally, co-exposure to sulpiride or SH-23390 respectively blocked the CLP or SLH response produced by U50,488 or bremazocine. Our data indicate the presence of kappa opioid receptors in planaria and suggest the functional interaction between the opioid and dopamine system in this simple animal model.

Pain
Arousal
Morphine
Tramadol
Why itch?
Nociceptin
Methadone
Endomorphins
P-glycoprotein
Morphine worms
Opiated crickets
Novelty and pain
Discounting rewards
Fentanyl and ketamine
Opioids, mood and cognition
Opioids, dopamine and alcohol
Opioids, goldfish and the giant toad
Heroin, cocaine and the squirrel monkey

Refs
HOME
HedWeb
cannabis-marijuana.com
BLTC Research
Designer Drugs
Paradise-Engineering
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?